We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Adjuvant.
ipros is IPROS GMS IPROS One of the largest technical database sites in Japan that collects information on.

Adjuvant - List of Manufacturers, Suppliers, Companies and Products

Adjuvant Product List

1~2 item / All 2 items

Displayed results

[Technology and Achievements] Formulated Products

Diverse approaches to the manufacturing of additives! We have successfully developed and launched products globally.

We will introduce our representative formulation technology along with specific examples. The "composite preparation" has successfully developed all four approaches, including single-layer single-group tablets, single-layer two-group tablets, layered tablets, and core tablets / active ingredient coated tablets. We have a proven track record of launching these globally. We respond to all requests related to CMC from the early stages of development to application. Please feel free to contact us when needed. 【Four Approaches】 ■ Single-layer single-group tablets ■ Single-layer two-group tablets ■ Layered tablets ■ Core tablets / active ingredient coated tablets *For more details, please refer to the PDF materials or feel free to contact us.

  • Other contract services
  • Technology Development

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

【Technology and Achievements Introduction】Formulation (Nucleated Tablets)

Successfully achieved complete separation and miniaturization of the main drug! We are developing a combination product as a nucleated tablet.

We will introduce our representative formulation technology along with specific examples. The combination product of a proton pump inhibitor (a treatment for peptic ulcers) and low-dose aspirin has been developed and launched as a formulation containing 100mg of aspirin and 15mg of proton pump inhibitor per tablet. Its usefulness, including formulation characteristics, has been highly evaluated. We respond to all requests related to CMC from the early stages of development to application. Please feel free to contact us when needed. 【Features】 ■ Complete separation to avoid interactions between active ingredients ■ Maintenance of the formulation system equivalent to that of a single agent (BE) ■ Miniaturization while maintaining formulation strength *For more details, please refer to the PDF materials or feel free to contact us.

  • Other contract services
  • Technology Development

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration